The pathogenesis of AD has not only been related to skin microorganisms, but also to gut microbiota
A note on dosage: The Salehpour study used 3,000 mg/day
Preparing the skin Cleansing removes the sebum, dead cells, and product residue that block peptide penetration
5.2 The relationship between migraine and neurogenic inflammation 5.2.1 Clinical evidence of neurogenic inflammation Increased blood expression of cytokines has been reported in migraineurs, both adults and children
Novel peptide therapies in clinical development Beyond the established peptides, several novel peptide-based treatments are advancing through preclinical and clinical pipelines specifically for eczema
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism